SCHEMBL5314933

SCHEMBL5314933

CC(C)c1nc(-c2ccc(N)cc2)no1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.50
TSHR P16473 4/20 0.45
MAPK1 P28482 3/20 0.45
ALDH1A1 P00352 2/20 0.45
LMNA P02545 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
CASP1 P29466 1/20 0.45
RAB9A P51151 1/20 0.45
ATM Q13315 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ACHE P22303 2/20 0.43
ACACB O00763 6/20 0.43
PPARD Q03181 4/20 0.43
PPARA Q07869 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TP53 P04637 1/20 0.42
NOTUM Q6P988 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12126068 0.87 HTT (0.51) HTTTSHRMAPK1ALDH1A1LMNA
SCHEMBL8592523 0.84 HTT (0.51) HTTTSHRMAPK1ALDH1A1LMNA
SCHEMBL12188525 0.84 SMN1; SMN2 (0.57) HTTTSHRMAPK1ALDH1A1LMNA
SCHEMBL23558949 0.82 RAB9A (0.51) HTTTSHRMAPK1ALDH1A1LMNA
SCHEMBL15299241 0.82 RAB9A (0.57) HTTTSHRMAPK1ALDH1A1LMNA
SCHEMBL6112891 0.82 PPARD (0.56) HTTTSHRMAPK1ALDH1A1LMNA
SCHEMBL12251791 0.82 NR1H4 (0.56) HTTMAPTRAB9ASMN1; SMN2L3MBTL1
SCHEMBL21332316 0.82 HDAC4 (0.43) ALDH1A1KDM4EMAPTHPGDRAB9A
SCHEMBL6978731 0.81 HTT (0.62) HTTTSHRMAPK1ALDH1A1KDM4E
SCHEMBL11020935 0.81 SMN1; SMN2 (0.59) HTTTSHRALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135442-A1 Chroman compounds ASTRAZENECA AB (SE) 2007-06-14 US disclosed
US-20070135442-A1 Chroman compounds ASTRAZENECA AB (SE) 2007-06-14 US disclosed
US-20070135442-A1 Chroman compounds ASTRAZENECA AB (SE) 2007-06-14 US disclosed
WO-2007053094-A1 CHROMAN COMPOUNDS AS 5 -HTlB ANTAGONISTS ASTRAZENECA AB (SE) 2007-05-10 WO disclosed
WO-2007053094-A1 CHROMAN COMPOUNDS AS 5 -HTlB ANTAGONISTS ASTRAZENECA AB (SE) 2007-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135442-A1 Chroman compounds CYP3A43, CYP2C9, CYP2C8 HTT 1087/4885TSHR 156/4885MAPK1 2276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.